| 14 |
DA-1241 Global Phase 2 Part 1 Patient Recruitment Completed
|
2024-04-05 |
1450 |
| 13 |
Dong-A ST, STGen Bio, ST Pharm's Triangular Partnership at Songdo Bio Hub
|
2024-04-05 |
2527 |
| 12 |
IMBiologics partners with Dong-A ST for novel antibody drug development
|
2024-02-19 |
1220 |
| 11 |
Dong-A ST partners with KIST for breakthrough in inflammatory bowel disease treatment
|
2024-02-19 |
1161 |
| 10 |
Dong-A ST NeuroBo Pharmaceuticals Initiates Phase 2 Part 2 Clinical Trial for DA-1241
|
2024-02-19 |
968 |
| 9 |
Dong-A ST Signs R&D Agreement with Eleven Therapeutics for RNA-based Gene Therapy
|
2024-01-15 |
1323 |
| 8 |
Dong-A ST acquires AbTis to develop new ADCs
|
2024-01-15 |
1895 |
| 7 |
Dong-A ST advances phase 1/2a study of cancer immunotherapy
|
2023-12-19 |
925 |
| 6 |
Dong-A ST to develop AAV gene therapy in collaboration with UMass Chan
|
2023-12-19 |
963 |
| 5 |
Dong-A ST Gears Up for Global Growth at CPHI Worldwide 2023 in Barcelona
|
2023-12-19 |
1104 |
